Reflection Asset Management’s Novo Nordisk NVO Stock Holding History

Reflection Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$21.5K	Buy	+395	New	+$20.2K	0.02%	368

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Reflection Asset Management's NVO Position: Q4 2025 in Review

Reflection Asset Management opened a new position in Novo Nordisk (NVO) in Q4 2025: 395 shares worth $21.5K. The stake represents 0.02% of the portfolio and ranks #368 among its holdings.

1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

Reflection Asset Management held 395 shares of Novo Nordisk worth $21.5K as of Q4 2025.
Novo Nordisk was a new Reflection Asset Management position in Q4 2025.
Novo Nordisk made up 0.02% of Reflection Asset Management's portfolio in Q4 2025, its #368 holding.
1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Reflection Asset Management's 13F filing for Q4 2025, filed 2 Mar 2026.